Study identifies new therapeutic target for most common type of pancreatic cancer
CDC urges Pfizer booster for children ages 5 to 11
20 May 2022Researchers highlight crisis in dental care for people with severe mental illness
20 May 2022Study identifies new therapeutic target for most common type of pancreatic cancer
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
